Hexarelin Research for Cardioprotection
An evidence-based overview of research examining Hexarelin in the context of cardioprotection. This page synthesizes findings from peer-reviewed literature.
Research Summary
Hexarelin exhibits cardioprotective effects via myocardial GH secretagogue receptor binding, independent of GH release. Animal studies showed reduced infarct size in ischemia-reperfusion. Human studies demonstrated increased left ventricular ejection fraction. This GH-independent cardiac benefit distinguishes hexarelin from other GHRPs.
Referenced Studies
Click any PMID to view the full study on PubMed.
Important Disclaimer
This page summarizes research findings and does not constitute medical advice. Hexarelin may have regulatory approval for some indications but should only be used under qualified medical supervision. Always consult a healthcare provider before making health decisions.